Table of Contents Author Guidelines Submit a Manuscript
Journal of Spectroscopy
Volume 2013 (2013), Article ID 796984, 10 pages
http://dx.doi.org/10.1155/2013/796984
Research Article

Utilization of a Green Brominating Agent for the Spectrophotometric Determination of Pipazethate HCl in Pure Form and Pharmaceutical Preparations

1Chemistry Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt
2Makkah Community College, Umm Al-Qura University, Makkah, Saudi Arabia

Received 1 December 2012; Revised 21 March 2013; Accepted 23 March 2013

Academic Editor: Reza Hajian

Copyright © 2013 Ayman A. Gouda. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, Merck, New York, NY, USA, 13th edition, 2001.
  2. S. C. Sweetman, Martindale: The Complete Drug Reference, Pharmaceutical Press, London, UK, 35th edition, 2011.
  3. E. G. C. Clarke, Clarke’s Analysis of Drugs and poisons in Pharmaceutical, Body Fluids and Postmortem Material, Pharmaceutical Press, London, UK, 3rd edition, 2004.
  4. Manufacturer procedure, EIPICO (Egyptian International Pharmaceutical Industries Co.), 10th of Ramadan City, Egypt, 2007.
  5. H. D. Revanasiddappa and P. G. Ramappa, “Reverse phase high-performance liquid chromatographic determination of pipazethate hydrochloride and thioproperazine mesylate in tablets,” Indian Drugs, vol. 32, no. 11, pp. 534–536, 1995. View at Google Scholar · View at Scopus
  6. G. M. Hadad, R. A. Abdel Salam, and S. Emara, “Validated stability—indicating HPTLC and HPLC methods for determination of pipazethate and its degradant,” Journal of Liquid Chromatography & Related Technologies A, vol. 34, no. 17–20, pp. 1850–1869, 2011. View at Google Scholar
  7. H. D. Revanasiddappa and P. G. Ramappa, “A new thin-layer chromatographic system for the identification of phenothiazine drugs,” Indian Drugs, vol. 32, no. 2, pp. 73–77, 1995. View at Google Scholar · View at Scopus
  8. H. D. Revanasiddappa, B. Manju, and H. Ramachandra, “Gas chromatographic determination of pipazethate hydrochloride and thioproperazine mesylate,” Indian Drugs, vol. 39, no. 11, pp. 589–592, 2002. View at Google Scholar · View at Scopus
  9. Y. M. Issa, A. F. Shoukry, and R. M. El-Nashar, “Conductimetric determination of reproterol HCl and pipazethate HCl and salbutamol sulphate in their pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 26, no. 3, pp. 379–386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. N. T. Abdel-Ghani, A. F. Shoukry, and R. M. El Nashar, “Flow injection potentiometric determination of pipazethate hydrochloride,” Analyst, vol. 126, no. 1, pp. 79–85, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. S. Zarapker, R. V. Rele, and V. J. Doshi, “Simple extractive colorimetric determination of three drugs from pharmaceutical preparations,” Indian Drugs, vol. 24, pp. 560–564, 1987. View at Google Scholar
  12. A. M. Hassan, A. F. El-Asmy, and Y. B. Abd El-Raheem, “Sensitive extractive simpler spectrophotometric methods for the microdetermination of diltiazem HCl and pipazethate HCl in pure and tablet dosage forms,” Asian Journal of Research in Chemistry, vol. 4, no. 9, pp. 1489–1498, 2011. View at Google Scholar
  13. M. B. Melwanki, J. Seetharamappa, and S. P. Masti, “Spectrophotometric determination of molybdenum(VI) using isothipendyl hyrochloride and pipazethate hyrochloride in alloy steels and soil samples,” Analytical Sciences, vol. 17, no. 9, pp. 1121–1123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. R. El-Shiekh, A. S. Amin, F. Zahran, and A. A. Gouda, “Spectrophotometric determination of pipazethate hydrochloride in pure form and in pharmaceutical formulations,” Journal of AOAC International, vol. 90, no. 3, pp. 686–692, 2007. View at Google Scholar · View at Scopus
  15. R. El-Shiekh, F. Zahran, and A. A. El-Fetouh Gouda, “Spectrophotometric determination of some anti-tussive and anti-spasmodic drugs through ion-pair complex formation with thiocyanate and cobalt(II) or molybdenum(V),” Spectrochimica Acta Part A, vol. 66, no. 4-5, pp. 1279–1287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. Amin, R. El-Sheikh, F. Zahran, and A. A. E. F. Gouda, “Spectrophotometric determination of pipazethate HCl, dextromethorphan HBr and drotaverine HCl in their pharmaceutical preparations,” Spectrochimica Acta Part A, vol. 67, no. 3-4, pp. 1088–1093, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. E. F. Gouda, R. El-Sheikh, Z. El Shafey, N. Hossny, and R. El-Azzazy, “Spectrophotometric determination of pipazethate HCl and dextromethorphan HBr using potassium permanganate,” International Journal of Biomedical Science, vol. 4, no. 4, pp. 294–302, 2008. View at Google Scholar · View at Scopus
  18. A. A. Gouda, R. El Sheikh, and A. S. Amin, “Spectrophotometric determination of some anti-tussive drugs and its applications to pharmaceutical formulations,” Analytical Chemistry, vol. 7, no. 10, pp. 757–767, 2008. View at Google Scholar
  19. Y. S. El-Saharty, N. A. El-Ragehy, H. M. Abdel-Monem, and M. I. Abdel-Kawy, “Stability-indicating methods for the determination of pipazethate HCl in the presence of its alkaline degradation product,” Journal of Advanced Research, vol. 1, no. 1, pp. 71–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. E. B. Sandell, Colorimetric Determination of Traces of Metals, Interscience Publishers, New York, NY, USA, 3rd edition, 1959.
  21. J. Mendham, R. C. Denney, J. D. Barnes, and M. Thomas, Vogel’S Textbook of Quantitative Chemical Analysis, Pearson Education, England, UK, 2000.
  22. J. C. Miller and J. N. Miller, Statistics and Chemometrics for Analytical Chemistry, Prentice Hall, England, UK, 5th edition, 2005.
  23. International Conference On Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procadures: Text and Methodology Q2(R 1), Complimentary Guideline on Methodology, incorporated in November 2005, London, UK, 1996.